New device could accelerate development of T-cell immunotherapies for cancer

Provider availability linked to COVID-19 vaccine uptake in children
1 July 2022
Researchers shed light on importance of ecological cellular interactions in targeted therapy resistance in lung cancer
1 July 2022

New device could accelerate development of T-cell immunotherapies for cancer

Imperial researchers have invented a device that can rapidly select T-cells that are most effective at attacking cancer cells.

Comments are closed.